Literature DB >> 20888105

Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs.

Sanjib Kumar Sharma1, Hequn Zou, Ariunaa Togtokh, Bogdan Ene-Iordache, Sergio Carminati, Andrea Remuzzi, Natasha Wiebe, Bharati Ayyalasomayajula, Norberto Perico, Giuseppe Remuzzi, Marcello Tonelli.   

Abstract

BACKGROUND: In 2007, the International Society of Nephrology funded the Kidney Disease Data Center database to house data from sponsored programs aimed at preventing chronic kidney disease and its complications in developing nations. This study compares baseline characteristics and burden of illness among participants from centers in China, Mongolia, and Nepal. An important secondary objective is to show the feasibility of screening for chronic kidney disease and its major risk factors in a diverse group of lower income settings. STUDY
DESIGN: Cross-sectional screening study. SETTING & PARTICIPANTS: Participants from Nepal (n = 8,398), China (n = 1,999), and Mongolia (n = 997). Screening was open to the public for participants in China and Nepal; referral from a general practitioner was required for participants in Mongolia. OUTCOMES: Estimated glomerular filtration rate (eGFR), proteinuria, hypertension, diabetes, obesity, cardiovascular risk. MEASUREMENT: Demographic and clinical data were collected prospectively using a standard format. Blood and urine specimens were provided according to local protocol.
RESULTS: Of 11,394 participants, decreased eGFR (<60 mL/min/1.73 m(2)) was present in 7.3%-14% of participants across centers; proteinuria (≥1+) on dipstick (2.4%-10%), hypertension (26%-36%), diabetes (3%-8%), and obesity (body mass index ≥30 kg/m(2); 2%-20%) were all common. Predicted 5-year cardiovascular risk ≥10% ranged from 20%-89%. Numbers needed to screen to detect a new case of eGFR <60 mL/min/1.73 m(2), hypertension, or diabetes were 2.6 (95% CI, 2.5-2.7), 3.4 (95% CI, 3.1-3.7), and 4.7 (95% CI, 3.3-8.0) for Nepal, China, and Mongolia, respectively. LIMITATIONS: May not be representative of the general population.
CONCLUSIONS: The acceptable diagnostic yield of abnormalities across these 3 diverse settings suggests that trials of targeted screening and intervention are feasible and warranted in such countries.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20888105     DOI: 10.1053/j.ajkd.2010.06.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  29 in total

Review 1.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Blood lead and cadmium levels and renal function in Korean adults.

Authors:  Sungjin Chung; Jong Hee Chung; Sung Jun Kim; Eun Sil Koh; Hye Eun Yoon; Cheol Whee Park; Yoon Sik Chang; Seok Joon Shin
Journal:  Clin Exp Nephrol       Date:  2013-11-26       Impact factor: 2.801

3.  MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.

Authors:  Hui Tang; Di Fan; Chun-Tao Lei; Chen Ye; Pan Gao; Shan Chen; Xian-Fang Meng; Hua Su; Chun Zhang
Journal:  J Mol Med (Berl)       Date:  2016-08-03       Impact factor: 4.599

4.  Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases.

Authors:  Qiwen Fang; Xiaoyi Wang; Zhenqiu Liu; Ming Zhu; Min Ding; Veenu Minhas; Charles Wood; Tiejun Zhang
Journal:  J Med Virol       Date:  2017-09-22       Impact factor: 2.327

5.  Elevated levels of protein in urine in adulthood after exposure to the Chinese famine of 1959-61 during gestation and the early postnatal period.

Authors:  Cheng Huang; Chaoran Guo; Catherine Nichols; Shuo Chen; Reynaldo Martorell
Journal:  Int J Epidemiol       Date:  2014-10-08       Impact factor: 7.196

6.  Ischemic heart disease and its related factors in Mongolia: a nationwide survey.

Authors:  Tsogzolbaatar Enkh-Oyun; Kazuhiko Kotani; Dambadarjaa Davaalkham; Yasuko Aoyama; Satoshi Tsuboi; Taeko Oguma; Yosikazu Nakamura
Journal:  J Community Health       Date:  2013-10

7.  Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis.

Authors:  Matheus Correa-Costa; Vinicius Andrade-Oliveira; Tarcio T Braga; Angela Castoldi; Cristhiane F Aguiar; Clarice S T Origassa; Andrea C D Rodas; Meire I Hiyane; Denise M A C Malheiros; Francisco J O Rios; Sonia Jancar; Niels O S Câmara
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

Review 8.  Prevalence of hypertension and prehypertension in Nepal: a systematic review and meta-analysis.

Authors:  Yun Huang; Pi Guo; Biraj M Karmacharya; Sharvesh Raj Seeruttun; Dong Roman Xu; Yuantao Hao
Journal:  Glob Health Res Policy       Date:  2019-04-30

9.  Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study.

Authors:  Reza Mohebi; Mohammadreza Bozorgmanesh; Farhad Sheikholeslami; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-03-13       Impact factor: 3.738

10.  Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA.

Authors:  Paolo Cravedi; Sanjib Kumar Sharma; Rodolfo Flores Bravo; Nazmul Islam; Irma Tchokhonelidze; Madhav Ghimire; Bishnu Pahari; Sanjeev Thapa; Anil Basnet; Avtandil Tataradze; Davitaia Tinatin; Lela Beglarishvili; Chyng-Wen Fwu; Jeffrey B Kopp; Paul Eggers; Bogdan Ene-Iordache; Sergio Carminati; Annalisa Perna; Antonietta Chianca; William G Couser; Giuseppe Remuzzi; Norberto Perico
Journal:  BMJ Open       Date:  2012-09-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.